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1. Introduction 
Thiocarbonyl compounds are useful and attractive tools for 
organic synthesis, especially as reactive synthetic intermediates,1 
even though such compounds are generally unstable. The 
structurally simple building block thioacetophenone is quite 
unstable in the monomeric form and can exist in a cyclic trimeric 
form, that is, 2,4,6-trimethyl-2,4,6-triphenyl-1,3,5-trithiane.2 In 
another instance, Motoki and coworkers reported that the 
thionation of chalcone with tetraphosphorus decasulfide (P4S10, 
Berzelius reagent)3 in carbon disulfide proceeded readily to give 
the corresponding thione dimer in moderate yield.4 On the other 
hand, experimental and theoretical observations have indicated 
that neighboring group effects influenced the stability and the 
reactivity of the thiocarbonyl group.5-7 Moreover, the electronic 
effects of the neighboring functional groups,8 such as the 4,4’-
bis(N,N-dimethylamino)phenyl group of thio-Michler’s ketone,8c 
have also been involved in the stability of the thiocarbonyl group. 
The choice of thionating agent is also particularly essential for 
the study of thiocarbonyl compounds. The representative 
thionating agents in organic synthesis are P4S10
3 and Lawesson’s 
reagent (LR)9, and the latter has tended to be used more 
frequently due to its broad solubility and better yields of the 
products. At present, the thionation mechanism of both reagents 
and their related derivatives10 are not completely clear, although 
it has been generally accepted that the dithiophosphine ylides (R-
PS2) generated in situ upon heating are the reactive species.
3a,8b,11 
 
Scheme 1. Synthesis of 1,3,5-trioxazatriquinane compounds and the 
discovery of novel adamantane-like cage structures. 
Recently, we reported the effective synthesis of 1,3,5-
trioxazatriquinane skeletons from the corresponding 
acetophenones and their curious opioid receptor agonistic 
activities.12 Based on this research background, we envisioned 
the design and synthesis of 1,3,5-trithiazatriquinane derivatives 
from the corresponding thioacetophenones generated in situ. 
However, we found that the thionating conditions of 
acetophenone derivatives with P4S10 formed an unprecedented 
adamantane-like cage structure consisting of phosphorus, sulfur, 
and carbon atoms (Scheme 1). In addition, the adamantane-like 
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compound showed a good thionating ability. We describe 
herein the details of our findings. 
2. Results and discussion 
The reaction of acetophenone (1a) with 10 equivalents of 
P4S10 for 20 hours in refluxing benzene followed by 
recrystallization from chloroform gave a colorless crystal. The 1H 
NMR and 13C NMR spectra of the unknown compound suggested 
the disappearance of a methyl group and a connection between a 
phosphorus and a carbon. The 31P NMR spectrum showed the 
existences of two equivalent phosphorus atoms and another 
phosphorus atom at 56.7, 62.0 ppm, respectively. Finally, X-ray 
crystallography revealed the structure of the unknown compound 
as a novel adamantane-like cage compound 2a (Scheme 2).13 
Intriguingly, in terms of the structural features, the reactive PS2 
moiety was removed from P4S10, and the acetyl group of 1a 
seemed to be embedded into the site of the residual P3S8. As for 
physical properties, the adamantane-like cage compound 2a was 
sensitive to polar solvents such as THF, DMF, acetone, methanol, 
and DMSO, although 2a was fairly stable and storable at room 
temperature for at least 2 months under an argon atmosphere. 
 
Scheme 2. Synthesis of 2a and the X-ray structure of 2a. 
To gain insight into the formation of 2a, we attempted to 
optimize the reaction conditions using 1a (Table 1). The yield of 
2a was similar when the reaction was carried out under reflux in 
either benzene or toluene (Entries 1 and 2). However, the 
formation of 2a and the decomposition of 2a proceeded 
simultaneously as indicated by TLC analysis when toluene was 
used. In addition, the product 2a seemed to gradually decompose 
at high temperature (Entries 2 and 3), and halogen solvents were 
also unsuitable for this reaction (Entries 4 and 5). Therefore, 
benzene was selected as the solvent of choice. With regards to 
the reaction time, the yield of 2a was gradually increased over 
time, even though the starting material 1a was consumed without 
a trace within one hour (Entries 1 and 6). However, prolonged 
reaction time led to the decomposition of 2a (Entry 7). When 1.0 
equivalent of P4S10 was used, the reaction gave only trace 
amounts of the desired 2a together with 2,5-diphenylthiophene 
(3a) in 16% yield as a by-product (Entry 8).14 In contrast, when 
5.0 equivalents of P4S10 was used, the yield of 2a was 
comparable to that of Entry 1 (Entry 9). In addition, the 
temperature was also a critical factor for this reaction; the 
formation of 2a barely proceeded even at 60 °C (Entries 10 and 
11). A short silica gel column chromatography before 
recrystallization led to the stable yield of 2a (Entry 1, 46% yield 
in parentheses). This outcome indicated that 2a and the similar 
derivatives 2 were rather stable toward silica gel column 
chromatography and we could, therefore, select the appropriate 
purification methods depending on the type of products formed. 
Table 1 
Optimization of reaction conditions. 
 
Entry Solvent X (equiv) Temp (°C) Time (h) Yield (%)a 
1 Benzene 10 Reflux 20 46 (46)b 
2 Toluene 10 Reflux 20 52 
3 Xylene 10 Reflux 20  9 
4 CCl4 10 Reflux 20 19 
5 (CH2Cl)2 10 Reflux 20 27 
6 Benzene 10 Reflux  4 26 
7 Benzene 10 Reflux 60 37 
8 Benzene 1 Reflux 20 tracec 
9 Benzene 5 Reflux 20 42 
10 Benzene 10 RT 20 trace 
11 Benzene 10 60 20 4 
a Isolated yield through recrystallization from chloroform.  
b Isolated yield through a short silica gel column with chloroform followed by 
recrystallization from chloroform.  
c 3a was isolated (16%). 
After establishing the optimized reaction conditions, we 
examined the generality of this promising reaction using a variety 
of acetophenone derivatives 1 and P4S10 (Table 2). Although all 
reaction systems could not be monitored by TLC due to the 
presence of multiple spots, the simple purification operation 
(short column chromatography followed by recrystallization, or 
recrystallization alone) gave the corresponding adamantane-like 
cage compounds 2 easily. The tendencies of these reactions were 
as follows: (i) the reactions of 2’-substituted 1b, 1c, and 1d gave 
2b, 2c, and 2d, respectively, in relatively low yields, although the 
reaction of 1e gave no detectable compounds (Entries 1–4); (ii) 
the reactions of 3’-substituted acetophenones, with the exception 
of 1h, gave the corresponding 2 in relatively high yields (Entries 
5–8); (iii) the reactions of 4’-substituted 1j, 1l, and 1m generated 
2,4-bis(4-methoxyphenyl)thiophene (4j),15 2,5-bis(4-
bromophenyl)thiophene (3l),14b,14c,14e,14h and 2,5-bis(4-
nitrophenyl)thiophene (3m),16 respectively (Entries 9, 11, and 12). 
All the NMR spectra of these derivatives 2b–2m corresponded to 
that of 2a. Interestingly, the 31P NMR showed the phosphorus 
atoms are affected by the electron-withdrawing group on the 
phenyl group (2a: 56.7, 62.0 ppm, 2h: 55.7, 60.9 ppm, 2i: 54.8, 
60.1 ppm, 2l: 56.0, 61.3 ppm, also see Table S1 in Supporting 
Information), although the substituent and the phosphorus atoms 
are relatively distant from each other. The X-ray structures of 2c 
bearing an electron-donating group and 2i bearing an electron-
withdrawing group revealed that both derivatives also have the 
same adamantane-like framework (Fig. 1, see Supporting 
Information). 
Table 2 
Synthesis of the adamantane-like cage compounds 2. 
 
Entry R (1)  Obtained Product Yields (%) 
1a 2’-MeO (1b) 2b: 14 
2a 2’-Me (1c) 2c: 10  
3a 2’-Br (1d) 2d: trace 
4a 2’-NO2 (1e) N.D.
c 
5a 3’-MeO (1f) 2f: 39  
 3 
6a 3’-Me (1g) 2g: 46 
7a 3’-Br (1h) 2h: 29 
8a 3’-NO2 (1i) 2i: 10 
9b 4’-MeO (1j) 2j: 14 + 4j: 14 
10a 4’-Me (1k) 2k: 38 
11b 4’-Br (1l) 2l: 32 + 3l: 16 
12a 4’-NO2 (1m) 2m: trace + 3m: 6  
a Purification: short silica gel column with chloroform followed by 
recrystallization from chloroform.  
b Purification: recrystallization from chloroform.  
c N.D. = not detected any adamantane derivatives. 
 
Fig. 1. The X-ray structures of 2c and 2i. 
The plausible reaction mechanisms for the formation of 2a are 
illustrated in Scheme 3, although the reactivity of P4S10 is quite 
complicated and not yet fully clarified.3a,11c,17 Path A in Scheme 3 
is based on the formation of thioacetophenone in situ. In 
refluxing solvents, P4S10 dissociates into P2S5 (I) and then, the 
desired thioacetophenone is formed through forming four-
membered ring II.3a,8b,11b,11c,17b,17e,18 Because of the thiocarbonyl 
group tends to turn into a stable C–S bond,19 the more reactive 
enthiol form of thioacetophenone immediately reacts with the 
fragments I or III and the generated IV recombines with I to 
form 2a. On the other hand, path B is based on the direct reaction 
of acetophenone with P4S10.
20 In this plausible pathway, the 
temporary thionation of acetophenone occurs in P4S10-mediated 
species and the following reassembly of the adamantane-
framework gave 2a. 
 
Scheme 3. Possible mechanism for the formation of 2a. 
Surprisingly, we also found that a novel noradamantane-like 
cage compound 5, with one sulfur atom removed from 2b, was 
formed by the reaction of 1b with P4S10, when refluxing toluene 
was exchanged for benzene as the solvent (Scheme 4). The 
framework of 5, consisting of P, S, and C atoms, was determined 
by X-ray crystallographic analysis (see Supporting Information). 
To our knowledge, there have been only a few noradamantane 
skeletons consisting of three elements, such as Si, S, and C 
atoms,21 Se, S, and C atoms,21 C, N, and O atoms,22 Ge, Si, and 
S,23 or Sn, Si, and Se.23 
 
Scheme 4. Synthesis of 5 and the X-ray structure of 5. 
The structures of these adamantane-like cage compounds 2 are 
quite similar to that of P4S10. Therefore, we also examined the 
thionation of 4,4’-dimethoxybenzophenone (6) and N,N-
dimethylbenzamide (8) by using 2a as a thionating agent, 
compared with P4S10 and Lawesson’s reagent (LR) (Scheme 5). 
Each reaction was continued until the ketone 6 or the benzamide 
8 were completely consumed. As the results of the comparative 
experiments, the thionating ability of 2a was superior to those 
representative agents. One of the most remarkable observations 
was that 2a itself had no strong unpleasant smell, which is a 
significant problem for P4S10 and LR. In addition, these 
adamantane-like cage compounds 2 dissolved well in benzene or 
toluene, unlike P4S10. Therefore, considering the solubility and 
the substrate-selectivity, 2 might be a good thionating agent. 
 
Scheme 5. Thionation of 4,4’-dimethoxtbenzophenone (6) and N,N-
dimethylbenzamide (8), using 2a, P4S10, or LR. 
3. Conclusion 
In conclusion, the novel adamantane-like cage compounds 2 
and the noradamantane-like cage compound 5, consisting of the 
three elements, phosphorus, sulfur, and carbon, were synthesized 
by the reactions of acetophenone derivatives 1 with P4S10. These 
structurally interesting heterogeneous scaffolds and the synthetic 
method were previously unreported. The first isolations of these 
compounds 2 and 5 would assist in the full elucidation of the 
reactivity of P4S10. In addition, by using 2a, ketone and 
benzamide were successfully transformed into the corresponding 
thioketone and benzothioamide, respectively, in high yields. 
Therefore, the non-foul smelling, organic soluble 2a is expected 
to represent a new-generation of thionating agents. Further 
physicochemical properties of these cage compounds and the 
characterization of the intermediates leading to adamantane- or 
noradamantane-like compounds will be reported in the near 
future. 
4. Experimental section 
4.1. General 
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All melting points were determined on a Yanaco MP melting 
point (mp) apparatus and are uncorrected. Infrared spectra were 
recorded with a JASCO FT/IR 4100 spectrophotometer. 1H, 13C, 
and 31P NMR spectral data were obtained with JEOL JNM-ECS 
400 instruments. Chemical shifts are quoted in ppm using 
tetramethylsilane (δ = 0 ppm) as the reference for 1H NMR 
spectroscopy, CDCl3 (δ = 77.0 ppm) for 13C NMR spectroscopy, 
and 85% H3PO4 (δ = 0 ppm) for 31P NMR spectroscopy. Mass 
spectra were measured with a JEOL JMS-T100LP spectrometer. 
Elemental analysis was performed with a YANACO CHN-
CODER JM-10 model analyzer. Column chromatography was 
carried out on silica gel (spherical, neutral, 40–50 µm, Kanto 
Chemical Co., Japan). 
4.1.1. General Procedure 1: Synthesis of 2 (recrystallization 
alone):  
A mixture of acetophenone derivative 1 (0.860 mmol) and 
P4S10 (8.60 mmol) in benzene (5 mL) was stirred under refluxing 
temperature for 20 h. After cooling to room temperature, the 
reaction mixture was filtered through an 11G-4 glass filter and 
washed with CHCl3 (80 mL). The filtrate was evaporated at 
40 °C, and then the residue was purified by recrystallization from 
hexane/CHCl3 to give 2 as a solid. 
4.1.2. General Procedure 2: Synthesis of 2 (short silica gel 
column chromatography followed by recrystallization):  
A mixture of acetophenone derivative 1 (2.25 mmol) and 
P4S10 (22.5 mmol) in benzene (12 mL) was stirred under 
refluxing temperature for 20 h. After cooling to room 
temperature, the reaction mixture was filtered through an 11G-4 
glass filter and washed with CHCl3 (80 mL). The filtrate was 
evaporated at 40 °C, and then the residue was filtered through a 
silica gel column chromatography (CHCl3). The eluate was 
evaporated at 40 °C, and then the residue was purified by 
recrystallization from hexane/CHCl3 to give 2 as a solid. 
4.1.3. 7-Phenyl-2,4,6,8,9-pentathia-1,3,5-triphosphaadamantane 
1,3,5-trisulfide (2a).  
Using Procedure 1; Yield: 46% (179 mg), Colorless crystal; 
MP 184.2–184.7 °C; IR (KBr): 2920, 2873, 1459, 758, 710, 687, 
532 cm-1; 1H NMR (400 MHz, CDCl3) δ 3.14 (d, 2JHP = 11.2 Hz, 
2H), 7.57–7.61 (m, 3H), 7.62–7.67 (m, 2H); 13C NMR (100 MHz, 
CDCl3) δ 42.8 (d, 1JCP = 53.4 Hz), 70.3 (d, 2JCP = 8.6 Hz), 125.6, 
130.7 (×2), 132.0 (×2), 140.5; 31P NMR (160 MHz, CDCl3) δ 
56.7, 62.0; HRMS-ESI (m/z): [M + H]+ calcd for C8H8P3S8: 
452.7605, found: 452.7593; Anal Cacld for C8H7P3S8: C, 21.23; 
H, 1.56. Found: C, 21.09; H, 1.77. 
4.1.4. 7-(2-Methoxyphenyl)-2,4,6,8,9-pentathia-1,3,5-
triphosphaadamantane 1,3,5-trisulfide (2b).  
Using Procedure 2; Yield: 14% (146 mg), Colorless crystal; 
MP 180.2–180.8 °C; IR (KBr): 2935, 2914, 2833, 1459, 756, 687, 
532 cm-1; 1H NMR (400 MHz, CDCl3) δ 3.39 (d, 2JHP = 10.0 Hz, 
2H), 3.94 (s, 3H), 7.10 (d, J = 8.0 Hz, 1H), 7.14 (dd, J = 8.0, 8.0 
Hz, 1H), 7.54 (dd, J = 8.0, 8.0 Hz, 1H), 7.64 (d, J = 8.0 Hz, 1H); 
13C NMR (100 MHz, CDCl3) δ 42.5 (d, 1JCP = 50.6 Hz), 56.3, 
70.1 (d, 2JCP = 8.6 Hz), 114.0, 122.0, 126.62, 126.64, 133.0, 
157.7; 31P NMR (160 MHz, CDCl3) δ 56.3, 63.1; HRMS-ESI 
(m/z): [M + H]+ calcd for C9H10OP3S8: 482.7710, found: 
482.7699; Anal Cacld for C9H9OP3S8: C, 22.40; H, 1.88. Found: 
C, 22.66; H, 2.12. 
4.1.5. 7-(o-Tolyl)-2,4,6,8,9-pentathia-1,3,5-
triphosphaadamantane 1,3,5-trisulfide (2c).  
Using Procedure 2; Yield: 10% (183 mg), Colorless crystal; 
MP 166.2–166.7 °C; IR (KBr): 2916, 2885, 2861, 1459, 1389, 
758, 689, 527 cm-1; 1H NMR (400 MHz, CDCl3) δ 2.68 (s, 3H), 
3.21 (d, 2JHP = 11.6 Hz, 2H), 7.37–7.51 (m, 4H); 13C NMR (100 
MHz, CDCl3) δ 23.3, 44.2 (d, 1JCP = 53.4 Hz), 70.6 (d, 2JCP = 9.5 
Hz), 125.2, 127.8, 131.4, 135.9, 138.6, The ipso carbon peak was 
not observed.; 31P NMR (160 MHz, CDCl3) δ 56.6, 60.3; HRMS-
ESI (m/z): [M + H]+ calcd for C9H10P3S8: 466.7761, found: 
466.7747; Anal Cacld for C9H9P3S8: C, 23.17; H, 1.94. Found: C, 
23.02; H, 2.09. 
4.1.6. 7-(3-Methoxyphenyl)-2,4,6,8,9-pentathia-1,3,5-
triphosphaadamantane 1,3,5-trisulfide (2f). 
Using Procedure 2; Yield: 39% (419 mg), Colorless crystal; 
MP 181.1–181.7 °C; IR (KBr): 2922, 2869, 2830, 1460, 785, 691, 
533 cm-1; 1H NMR (400 MHz, CDCl3) δ 3.12 (d, 2JHP = 10.8 Hz, 
2H), 3.87 (s, 3H), 7.08 (dd, J = 8.2, 2.2 Hz, 1H), 7.14 (dd, J = 2.2, 
2.2 Hz, 1H), 7.20 (dd, J = 8.2, 2.2 Hz, 1H), 7.49 (dd, J = 8.2, 8.2 
Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 42.9 (d, 1JCP = 53.4 Hz), 
55.9, 111.7, 117.0, 117,1, 131.7, 141.8, 161.2, The quaternary 
carbon peak was not observed.; 31P NMR (160 MHz, CDCl3) δ 
56.7, 62.0; HRMS-ESI (m/z): [M + H]+ calcd for C9H10OP3S8: 
482.7710, found: 482.7728; Anal Cacld for C9H9OP3S8: C, 22.40; 
H, 1.88. Found: C, 22.27; H, 1.99. 
4.1.7. 7-(m-Tolyl)-2,4,6,8,9-pentathia-1,3,5-
triphosphaadamantane 1,3,5-trisulfide (2g). 
Using Procedure 2; Yield: 46% (480 mg), Colorless crystal; 
MP 168.6–168.7 °C; IR (KBr): 2915, 2865, 1459, 1389, 780, 692, 
533 cm-1; 1H NMR (400 MHz, CDCl3) δ 2.45 (s, 3H), 3.13 (d, 
2JHP = 10.8 Hz, 2H), 7.36–7.49 (m, 4H); 13C NMR (100 MHz, 
CDCl3) δ 21.8, 42.8 (d, 1JCP = 54.4 Hz), 122.4, 126.1, 130.5, 
132.8, 141.0, The ipso carbon peak and the quaternary carbon 
peak were not observed.; 31P NMR (160 MHz, CDCl3) δ 56.8, 
62.2; HRMS-ESI (m/z): [M + H]+ calcd for C9H10P3S8: 466.7761, 
found: 466.7762; Anal Cacld for C9H9P3S8: C, 23.17; H, 1.94. 
Found: C, 23.21; H, 1.98. 
4.1.8. 7-(3-Bromophenyl)-2,4,6,8,9-pentathia-1,3,5-
triphosphaadamantane 1,3,5-trisulfide (2h). 
Using Procedure 2; Yield: 29% (356 mg), Colorless crystal; 
MP 181.8–182.5 °C; IR (KBr): 2918, 2871, 1470, 1077, 795, 689, 
564, 536 cm-1; 1H NMR (400 MHz, CDCl3) δ 3.10 (d, 2JHP = 
10.8 Hz, 2H), 7.47 (dd, J = 8.0, 8.0 Hz, 1H), 7.59 (d, J = 8.4 Hz, 
1H), 7.71 (d, J = 8.4 Hz, 1H), 7.76–7.78 (m, 1H); 13C NMR (100 
MHz, CDCl3) δ 42.6 (d, 1JCP = 54.4 Hz), 69.5 (d, 2JCP = 7.6 
Hz), 124.2, 124.7, 128.7, 132.0, 135.1, 142.4; 31P NMR (160 
MHz, CDCl3) δ 55.7, 60.9; HRMS-ESI (m/z): [M + H]+ calcd 
for C8H779BrP3S8: 530.6710, found: 530.6731; Anal Cacld for 
C8H6BrP3S8: C, 18.08; H, 1.14. Found: C, 17.96; H, 1.28. 
4.1.9. 7-(3-Nitrophenyl)-2,4,6,8,9-pentathia-1,3,5-
triphosphaadamantane 1,3,5-trisulfide (2i). 
Using Procedure 2; Yield: 10% (137 mg), Pale yellow crystal; 
MP 196.0–196.8 °C; IR (KBr): 2926, 2868, 1523, 1459, 1348, 
778, 696, 533 cm-1; 1H NMR (400 MHz, CDCl3) δ 3.18 (d, 2JHP = 
11.2 Hz, 2H), 7.84 (dd, J = 8.0, 8.0 Hz, 1H), 8.03 (dd, J = 8.0, 
2.0 Hz, 1H), 8.46 (dd, J = 8.0, 2.0 Hz, 1H), 8.51 (dd, J = 2.0, 2.0 
Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 42.6 (d, 1JCP = 54.3 Hz), 
69.5 (d, 2JCP = 7.6 Hz), 120.9, 126.6, 131.8, 132.0, 142.5, 149.3; 
31P NMR (160 MHz, CDCl3) δ 54.8, 60.1; HRMS-ESI (m/z): [M 
+ H]+ calcd for C8H7NO2P3S8: 497.7455, found: 497.7478; Anal 
Cacld for C8H6NO2P3S8: C, 19.31; H, 1.22; N, 2.81. Found: C, 
19.24; H, 1.39; N, 2.89. 
 5 
4.1.10. 7-(4-Methoxyphenyl)-2,4,6,8,9-pentathia-1,3,5-
triphosphaadamantane 1,3,5-trisulfide (2j). 
Using Procedure 1; Yield: 14% (60.0 mg), Colorless crystal; 
MP 165.7–166.5 °C; IR (KBr): 2918, 2863, 2832, 1459, 684, 530 
cm-1; 1H NMR (400 MHz, CDCl3) δ 3.09 (d, 2JHP = 11.0 Hz, 2H), 
3.88 (s, 3H), 7.06 (d, J = 8.8 Hz, 2H), 7.55 (d, J = 8.8 Hz, 2H); 
13C NMR (100 MHz, CDCl3) δ 42.7 (d, 1JCP = 53.4 Hz), 55.9, 
69.9 (ddd, 2JCP = 8.2 Hz, 
2JCP = 8.2 Hz, 
2JCP = 8.2 Hz), 115.9 (×2), 
127.2 (×2), 132.3 (ddd, 3JCP = 21.1 Hz, 
3JCP = 8.1 Hz, 
3JCP = 8.1 
Hz), 162.1; 31P NMR (160 MHz, CDCl3) δ 57.5, 62.6; HRMS-
ESI (m/z): [M + H]+ calcd for C9H10OP3S8: 482.7710, found: 
482.7723; Anal Cacld for C9H9OP3S8: C, 22.40; H, 1.88. Found: 
C, 22.15; H, 2.09. 
4.1.11. 7-(p-Tolyl)-2,4,6,8,9-pentathia-1,3,5-
triphosphaadamantane 1,3,5-trisulfide (2k). 
Using Procedure 2; Yield: 38% (408 mg), Colorless crystal; 
MP 171.4–171.7 °C; IR (KBr): 2916, 2864, 1459, 1389, 805, 681, 
527 cm-1; 1H NMR (400 MHz, CDCl3) δ 2.44 (s, 3H), 3.11 (d, 
2JHP = 11.0 Hz, 2H), 7.37 (d, J = 8.4 Hz, 2H), 7.51 (d, J = 8.4 Hz, 
2H); 13C NMR (100 MHz, CDCl3) δ 21.5, 42.8 (d, 1JCP = 53.4 
Hz), 70.1 (d, 2JCP = 8.6 Hz), 125.4 (×2), 131.3 (×2), 137.6, 142.7; 
31P NMR (160 MHz, CDCl3) δ 57.1, 62.3; HRMS-ESI (m/z): [M 
+ H]+ calcd for C9H10P3S8: 466.7761, found: 466.7755; Anal 
Cacld for C9H9P3S8: C, 23.17; H, 1.94. Found: C, 22.97; H, 2.04. 
4.1.12. 7-(4-Bromophenyl)-2,4,6,8,9-pentathia-1,3,5-
triphosphaadamantane 1,3,5-trisulfide (2l). 
Using Procedure 1; Yield: 32% (99.0 mg), Colorless crystal; 
MP 205.2–205.6 °C; IR (KBr): 2924, 2876, 1459, 1077, 809, 693, 
534, 528 cm-1; 1H NMR (400 MHz, CDCl3) δ 3.09 (d, 2JHP = 11.6 
Hz, 2H), 7.51 (d, J = 8.6 Hz, 2H), 7.73 (d, J = 8.6 Hz, 2H); 13C 
NMR (100 MHz, CDCl3) δ 42.6 (d, 1JCP = 54.4 Hz), 69.6–69.9 
(m), 126.7, 127.2 (×2), 133.9 (×2), The ipso carbon peak was not 
observed.; 31P NMR (160 MHz, CDCl3) δ 56.0, 61.3; HRMS-ESI 
(m/z): [M + H]+ calcd for C8H7
79BrP3S8: 530.6710, found: 
530.6706; Anal Cacld for C8H6BrP3S8: C, 18.08; H, 1.14. Found: 
C, 17.91; H, 1.30. 
4.1.13. 7a-(2-Methoxyphenyl)dihydro-2,6-
epithio[1,2,5]thiadiphospholo[2,3-d][1,3,2,4]dithiadiphosphole 
2,4,6-trisulfide (5). 
Using Procedure 1; Yield: 5% (76.2 mg), Colorless crystal; 
MP 213.9–214.4 °C; IR (KBr): 2929, 2912, 2826, 1459, 750, 692, 
528 cm-1; 1H NMR (400 MHz, CDCl3) δ 3.38 (ddd, 2JHP = 39.6 
Hz, 14.4 Hz, 3JHP = 10.4 Hz, 1H), 3.87 (s, 3H), 4.46 (dd, J = 14.4 
Hz, 2JHP = 12.0 Hz, 1H), 7.03 (d, J = 8.0 Hz, 1H), 7.09 (dd, J = 
7.4, 7.4 Hz, 1H), 7.35–7.40 (m, 1H), 7.49–7.54 (m, 1H); 13C 
NMR (100 MHz, CDCl3) δ 55.2 (dd, 1JCP = 50.3 Hz, 2JCP = 11.4 
Hz), 55.6, 113.0 (d, J = 2.9 Hz), 119.9–120.0 (m), 121.8 (d, J = 
2.0 Hz), 126.9 (d, J = 6.7 Hz), 132.7 (d, J = 3.8 Hz), 156.7 (d, J = 
4.7 Hz), The quaternary carbon peak was not observed; 31P NMR 
(160 MHz, CDCl3) δ 55.0, 69.8, 124.1; HRMS-ESI (m/z): [M + 
H]+ calcd for C9H10OP3S7: 450.7989, found: 450.7992; Anal 
Cacld for C9H9OP3S7: C, 23.99; H, 2.01. Found: C, 23.83; H, 
2.09. 
4.1.14. Synthesis of 7. (Scheme 5): 
A mixture of 6 (25.0 mg, 0.105 mmol) and P4S10 (29.0 mg, 
0.0630 mmol) in toluene (2 mL) was stirred under refluxing 
temperature for 6 h. After the evaporation of the solvent, the 
residue was purified by silica gel column chromatography 
(hexane/ethyl acetate = 30/1) to give 724 as a dark blue solid (26.6 
mg, 98%). 
4.1.15. Synthesis of 9. (Scheme 5): 
A mixture of 8 (28.0 mg, 0.188 mmol) and P4S10 (51.0 mg, 
0.113 mmol) in toluene (2 mL) was stirred under refluxing 
temperature for 2 h. After the evaporation of the solvent, the 
residue was purified by silica gel column chromatography 
(hexane/ethyl acetate = 10/1) to give 925 as a pale yellow solid 
(27.8 mg, 89%). 
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